Checklist for NPCR and SEER Incidence – U.S. Cancer Statistics Public Use Database, 2005–2015 Analyses

  • If a user-defined primary site variable was created (rather than using the Site recode ICD-O-3/WHO 2008 variable)—
    • Did you exclude leukemias and lymphomas (9590–9992)?
    • Did you consider excluding Kaposi sarcoma (9140) and mesothelioma (9050–9055)?1
  • If your analysis includes histology, and if appropriate for the cancer site, did you use the Diagnostic Confirmation variable to specify the analysis be limited to Microscopically confirmed cases?2
  • If you are analyzing sex-specific cancers (such as prostate cancer or female breast cancer), did you limit the analysis to the appropriate sex to get the correct population denominator?3
  • When reporting rates, have you included the label “per 100,000 persons,” “per 100,000 women,” or “per 100,000 men”?
  • Have you included citations for the—
    • Percentage of United States population coverage provided by the database?
    • NPCR and SEER Incidence – U.S. Cancer Statistics 2005–2015 Public Use Research Database?4

References

1See data dictionary Cdc-pdf[PDF-758KB] – Cautionary Notes section entitled Primary Site Variables.

2See data dictionary Cdc-pdf[PDF-758KB]Diagnostic Confirmation variable descriptions.

3See data dictionary Cdc-pdf[PDF-758KB]Sex variable description.

4See data dictionary Cdc-pdf[PDF-758KB]Data Citation section.